rolipram has been researched along with Trypanosomiasis, African in 1 studies
Trypanosomiasis, African: A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the TSETSE FLY. Involvement of the central nervous system produces African sleeping sickness. Nagana is a rapidly fatal trypanosomiasis of horses and other animals.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bland, ND | 1 |
| Wang, C | 1 |
| Tallman, C | 1 |
| Gustafson, AE | 1 |
| Wang, Z | 1 |
| Ashton, TD | 1 |
| Ochiana, SO | 1 |
| McAllister, G | 1 |
| Cotter, K | 1 |
| Fang, AP | 1 |
| Gechijian, L | 1 |
| Garceau, N | 1 |
| Gangurde, R | 1 |
| Ortenberg, R | 1 |
| Ondrechen, MJ | 1 |
| Campbell, RK | 1 |
| Pollastri, MP | 1 |
1 other study available for rolipram and Trypanosomiasis, African
| Article | Year |
|---|---|
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Benzamides; Catalytic Domain; Humans; Models, Molecular; Molecu | 2011 |